Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Feb 2015 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for MBLTY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

02 Mar 2015 ValuEngine, Inc. 10 $25.00

Thomson Reuters Stock Report - MESOBLAST LTD (MSB-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Feb 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Industry Report for Medical-biomed/genetics(MBLTY)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

24 Feb 2015 ValuEngine, Inc. 10 $49.00

Mesoblast Limited

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Th...

17 Feb 2015 Acquisdata 11 $15.00

Are Mesoblast limited Investors in for a Bumpy Ride?

17 Feb 2015 Sadif Analytics Prime 12 $25.00

Mesoblast Limited - Improved Survival in Children with Graft Versus Host Disease Who Respond to Mesoblast's Cell Therapy

16 Feb 2015 irasia.com 2 $23.00

Mesoblast Limited - 2015 Half-Year Financial Results & Corporate Strategy

12 Feb 2015 irasia.com 27 $311.00

Mesoblast Limited - Appendix 4D - Half Year Report for the Six Months to 31 December 2014

12 Feb 2015 irasia.com 34 $391.00

Mesoblast Limited - Mesoblast 2015 Half-year Results

12 Feb 2015 irasia.com 3 $35.00